Circulation. 2005;112:3066-3072
Published online before print November 7, 2005, doi: 10.1161/CIRCULATIONAHA.105.539528
Published online before print November 7, 2005, doi: 10.1161/CIRCULATIONAHA.105.539528
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:3066-3072.)
© 2005 American Heart Association, Inc.
Epidemiology |
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
From the NHLBI’s Framingham Heart Study (P.W.F.W., R.B.D., H.P., L.S.), Framingham, Mass; Medical University of South Carolina (P.W.F.W.), Charleston, SC; Boston University Department of Mathematics (R.B.D., H.P., L.S.), Boston, Mass; and The General Medicine Division (J.B.M.), Department of Medicine, Massachusetts Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Dr Peter W.F. Wilson, Medical University of South Carolina, 96 Jonathan Lucas St, General Clinical Research Center, Clinical Sciences Bldg, Suite 815, Charleston, SC 29425. E-mail wilsonpw{at}musc.edu
Received January 28, 2005; revision received July 25, 2005; accepted August 26, 2005.
Background— The incidence of cardiovascular disease (CVD), coronary heart disease (CHD), and type 2 diabetes mellitus (T2DM) has not been well defined in persons with the metabolic syndrome (at least 3 of the following: abdominal adiposity, low HDL cholesterol, high triglycerides, hypertension, and impaired fasting glucose). The objective was to investigate risk for CVD, CHD, and T2DM according to metabolic syndrome traits.
Methods and Results— The study followed a cohort of 3323 middle-aged adults for the development of new CVD, CHD, and T2DM over an 8-year period. In persons without CVD or T2DM at baseline, the prevalence of the metabolic syndrome (
3 of 5 traits) was 26.8% in men and 16.6% in women. There were 174 incident cases of CVD, 107 of CHD, and 178 of T2DM. In men, the metabolic syndrome age-adjusted relative risk (RR) and 95% CIs were RR=2.88 (95% CI 1.99 to 4.16) for CVD, RR=2.54 (95% CI 1.62 to 3.98) for CHD, and RR=6.92 (95% CI 4.47 to 10.81) for T2DM. Event rates and RRs were lower in women for CVD (RR=2.25, 95% CI 1.31 to 3.88) and CHD (RR=1.54, 95% CI 0.68 to 3.53), but they were similar for T2DM (RR=6.90, 95% CI 4.34 to 10.94). Population-attributable risk estimates associated with metabolic syndrome for CVD, CHD, and T2DM were 34%, 29%, and 62% in men and 16%, 8%, 47% in women.
Conclusions— Metabolic syndrome is common and is associated with an increased risk for CVD and T2DM in both sexes. The metabolic syndrome accounts for up to one third of CVD in men and approximately half of new T2DM over 8 years of follow-up.
Key Words: diabetes mellitus • coronary disease • epidemiology • glucose • obesity
This article has been cited by other articles:
 |
|
 |
|
  A. Laudisio, E. Marzetti, F. Pagano, G. Pozzi, R. Bernabei, and G. Zuccala Depressive Symptoms and Metabolic Syndrome: Selective Association in Older Women J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 215 - 222. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E Rumawas, J. B Meigs, J. T Dwyer, N. M McKeown, and P. F Jacques Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort Am. J. Clinical Nutrition, December 1, 2009; 90(6): 1608 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mukai, Y. Doi, T. Ninomiya, J. Hata, K. Yonemoto, M. Iwase, M. Iida, and Y. Kiyohara Impact of Metabolic Syndrome Compared With Impaired Fasting Glucose on the Development of Type 2 Diabetes in a General Japanese Population: The Hisayama study Diabetes Care, December 1, 2009; 32(12): 2288 - 2293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden The 6th Annual World Congress on the Insulin Resistance Syndrome Diabetes Care, September 1, 2009; 32(9): e104 - e111. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Al-Sarraj, H. Saadi, M. C. Calle, J. S. Volek, and M. L. Fernandez Carbohydrate Restriction, as a First-Line Dietary Intervention, Effectively Reduces Biomarkers of Metabolic Syndrome in Emirati Adults J. Nutr., September 1, 2009; 139(9): 1667 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Czernichow, A.-C. Vergnaud, P. Galan, J. Arnaud, A. Favier, H. Faure, R. Huxley, S. Hercberg, and N. Ahluwalia Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults Am. J. Clinical Nutrition, August 1, 2009; 90(2): 329 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs Multiple Biomarker Prediction of Type 2 Diabetes Diabetes Care, July 1, 2009; 32(7): 1346 - 1348. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Uebanso, Y. Taketani, M. Fukaya, K. Sato, Y. Takei, T. Sato, N. Sawada, K. Amo, N. Harada, H. Arai, et al. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E76 - E84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagaya, H. Yoshida, H. Takahashi, and M. Kawai Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type-2 diabetes mellitus Int. J. Epidemiol., June 29, 2009; (2009) dyp229v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Johnson, J. J. M. Kroon, F. L. Greenway, C. Bouchard, D. Ryan, and P. T. Katzmarzyk Prevalence of Risk Factors for Metabolic Syndrome in Adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006 Arch Pediatr Adolesc Med, April 1, 2009; 163(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reaven Is diagnosing metabolic syndrome a uniquely simple way to predict incident type 2 diabetes mellitus? Can. Med. Assoc. J., March 17, 2009; 180(6): 601 - 602. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Ley, S. B. Harris, M. Mamakeesick, T. Noon, E. Fiddler, J. Gittelsohn, T. M.S. Wolever, P. W. Connelly, R. A. Hegele, B. Zinman, et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community Can. Med. Assoc. J., March 17, 2009; 180(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Amundson, M. K. Butcher, D. Gohdes, T. O. Hall, T. S. Harwell, S. D. Helgerson, K. K. Vanderwood, and for the Montana Cardiovascular Disease and Diabete Translating the Diabetes Prevention Program Into Practice in the General Community: Findings From the Montana Cardiovascular Disease and Diabetes Prevention Program The Diabetes Educator, March 1, 2009; 35(2): 209 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Adolphe, L. S. Cook, and X. Huang A Cross-sectional Study of Intima-Media Thickness, Ethnicity, Metabolic Syndrome, and Cardiovascular Risk in 2268 Study Participants Mayo Clin. Proc., March 1, 2009; 84(3): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Belin de Chantemele, E. Vessieres, A.-L. Guihot, B. Toutain, M. Maquignau, L. Loufrani, and D. Henrion Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow Cardiovasc Res, March 1, 2009; 81(4): 788 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF]
|
|
|
|
 |
|
 I. A Scott Evaluating cardiovascular risk assessment for asymptomatic people BMJ, January 5, 2009; 338(jan05_1): a2844 - a2844. [Full Text]
|
|
|
|
 |
|
 R. Dankner, G. Geulayov, L. Olmer, and G. Kaplan Undetected type 2 diabetes in older adults Age Ageing, January 1, 2009; 38(1): 56 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, Y. Zhang, B. Dorweiler, D. Cui, T. Wang, C. W. Woo, C. S. Brunkan, C. Wolberger, S.-i. Imai, and I. Tabas Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism J. Biol. Chem., December 12, 2008; 283(50): 34833 - 34843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden American College of Endocrinology Pre-Diabetes Consensus Conference: Part Three Diabetes Care, December 1, 2008; 31(12): 2404 - 2409. [Full Text] [PDF]
|
|
|
|
|
|
B. Aijaz, K. A. Ammar, F. Lopez-Jimenez, M. M. Redfield, S. J. Jacobsen, and R. J. Rodeheffer Abnormal Cardiac Structure and Function in the Metabolic Syndrome: A Population-Based Study Mayo Clin. Proc., December 1, 2008; 83(12): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. L. Strufaldi, E. M. K. Da Silva, and R. F. Puccini Metabolic syndrome among prepubertal Brazilian schoolchildren Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 291 - 297. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Suzuki, R. Katz, N. S. Jenny, N. A. Zakai, M. M. LeWinter, J. I. Barzilay, and M. Cushman Metabolic Syndrome, Inflammation, and Incident Heart Failure in the Elderly: The Cardiovascular Health Study Circ Heart Fail, November 1, 2008; 1(4): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3671 - 3689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau, H. A. Mostefai, C. Draunet-Busson, G. Leftheriotis, C. Heymes, M. C. Martinez, and R. Andriantsitohaina Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome Am. J. Pathol., October 1, 2008; 173(4): 1210 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Choi, M. A. De Vera, and E. Krishnan Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile Rheumatology, October 1, 2008; 47(10): 1567 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, C. Li, and N. Sattar Metabolic Syndrome and Incident Diabetes: Current state of the evidence Diabetes Care, September 1, 2008; 31(9): 1898 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, and A. P. DeFilippis A Practical 'ABCDE' Approach to the Metabolic Syndrome Mayo Clin. Proc., August 1, 2008; 83(8): 932 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Arenillas, L. Ispierto, M. Millan, D. Escudero, N. Perez de la Ossa, L. Dorado, C. Guerrero, J. Serena, J. Castillo, and A. Davalos Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke Neurology, July 15, 2008; 71(3): 190 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Wassink, Y. Van Der Graaf, S. S Soedamah-Muthu, W. Spiering, and F. L. Visseren Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 114 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B Panagiotakos, C. Pitsavos, C. Chrysohoou, I. Skoumas, and C. Stefanadis Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study Vascular Medicine, May 1, 2008; 13(2): 113 - 121. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland Stroke, April 1, 2008; 39(4): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson and J. B. Meigs Risk of type 2 diabetes mellitus and coronary heart disease: a pivotal role for metabolic factors Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B11 - B15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Group Members, W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
S. D De Ferranti and S. K Osganian Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 285 - 296. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Conen, P. M. Ridker, S. Mora, J. E. Buring, and R. J. Glynn Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study Eur. Heart J., December 1, 2007; 28(23): 2937 - 2943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto Metabolic Syndrome and Incident End-Stage Peripheral Vascular Disease: A 14-year follow-up study in elderly Finns Diabetes Care, December 1, 2007; 30(12): 3099 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Cull, C. C. Jensen, R. Retnakaran, and R. R. Holman Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study 78 Circulation, November 6, 2007; 116(19): 2119 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Duncan, S. J. Walker, V. A. Ezzat, S. B. Wheatcroft, J.-M. Li, A. M. Shah, and M. T. Kearney Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1311 - E1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Curtis, B. G. Hammill, M. A. Bethel, K. J. Anstrom, J. S. Gottdiener, and K. A. Schulman Costs of the Metabolic Syndrome in Elderly Individuals: Findings from the Cardiovascular Health Study Diabetes Care, October 1, 2007; 30(10): 2553 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guize, F. Thomas, B. Pannier, K. Bean, B. Jego, and A. Benetos All-Cause Mortality Associated With Specific Combinations of the Metabolic Syndrome According to Recent Definitions Diabetes Care, September 1, 2007; 30(9): 2381 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Insulin Resistance, Dyslipidemia, and Cardiovascular Disease Diabetes Care, August 1, 2007; 30(8): 2164 - 2170. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Morrison, L. A. Friedman, and C. Gray-McGuire Metabolic Syndrome in Childhood Predicts Adult Cardiovascular Disease 25 Years Later: The Princeton Lipid Research Clinics Follow-up Study Pediatrics, August 1, 2007; 120(2): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dhingra, L. Sullivan, P. F. Jacques, T. J. Wang, C. S. Fox, J. B. Meigs, R. B. D'Agostino, J. M. Gaziano, and R. S. Vasan Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community Circulation, July 31, 2007; 116(5): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Blaum, N. A. West, and M. N. Haan Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans? J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2007; 62(7): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jeppesen, T. W. Hansen, S. Rasmussen, H. Ibsen, C. Torp-Pedersen, and S. Madsbad Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2112 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. F. Wilson, J. B. Meigs, L. Sullivan, C. S. Fox, D. M. Nathan, and R. B. D'Agostino Sr Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study Arch Intern Med, May 28, 2007; 167(10): 1068 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, M. K. Rutter, L. M. Sullivan, C. S. Fox, R. B. D'Agostino Sr., and P. W.F. Wilson Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome Diabetes Care, May 1, 2007; 30(5): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn Metabolic Syndrome: Is It a Syndrome? Does It Matter? Circulation, April 3, 2007; 115(13): 1806 - 1811. [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns Eur. Heart J., April 1, 2007; 28(7): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Esmaillzadeh, M. Kimiagar, Y. Mehrabi, L. Azadbakht, F. B Hu, and W. C Willett Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women Am. J. Clinical Nutrition, March 1, 2007; 85(3): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks Hypertension, March 1, 2007; 49(3): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
|
|
A. De Lorenzo, V. Del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. Di Renzo Normal-weight obese syndrome: early inflammation? Am. J. Clinical Nutrition, January 1, 2007; 85(1): 40 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lorenzo, K. Williams, K. J. Hunt, and S. M. Haffner The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes Diabetes Care, January 1, 2007; 30(1): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. North, N. Franceschini, I. B. Borecki, C. C. Gu, G. Heiss, M. A. Province, D. K. Arnett, C. E. Lewis, M. B. Miller, R. H. Myers, et al. Genotype-by-Sex Interaction on Fasting Insulin Concentration: The HyperGEN Study Diabetes, January 1, 2007; 56(1): 137 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Aguilar-Salinas, R. Rojas, C. Gonzalez-Villalpando, F. J. Gomez-Perez, R. Mehta, G. Olaiz, J. A. Rull, and D. R. Cox Design and validation of a population-based definition of the metabolic syndrome. Diabetes Care, November 1, 2006; 29(11): 2420 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.D.H. Malnick and H. Knobler The medical complications of obesity QJM, September 1, 2006; 99(9): 565 - 579. [Full Text] [PDF]
|
|
|
|
|
|
N. Ishizaka, Y. Ishizaka, H. Hashimoto, E.-I. Toda, R. Nagai, and M. Yamakado Metabolic Syndrome May Not Associate With Carotid Plaque in Subjects With Optimal, Normal, or High-Normal Blood Pressure Hypertension, September 1, 2006; 48(3): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn The Metabolic Syndrome (Emperor) Wears No Clothes Diabetes Care, July 1, 2006; 29(7): 1693 - 1696. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Eckel, R. Kahn, R. M. Robertson, and R. A. Rizza Preventing Cardiovascular Disease and Diabetes: A call to action from the American Diabetes Association and the American Heart Association Diabetes Care, July 1, 2006; 29(7): 1697 - 1699. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Luchsinger A Work in Progress: The Metabolic Syndrome Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe19 - pe19. [Abstract] [Full Text]
|
|
|
|
|
|
R. H. Eckel, R. Kahn, R. M. Robertson, and R. A. Rizza Preventing Cardiovascular Disease and Diabetes: A Call to Action From the American Diabetes Association and the American Heart Association Circulation, June 27, 2006; 113(25): 2943 - 2946. [Full Text] [PDF]
|
|
|
|
|
|
G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schillaci, M. Pirro, G. Pucci, M. R. Mannarino, F. Gemelli, D. Siepi, G. Vaudo, and E. Mannarino Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women Hypertension, May 1, 2006; 47(5): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C Deedwania and R. Schmieder Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1_suppl): S12 - S18. [Abstract] [PDF]
|
|
|
|
 |
|
 The Path to Diabetes and Heart Disease DOC News, February 1, 2006; 3(2): 12 - 12. [Full Text]
|
|
|
|
|
|
G. Reaven Insulin Resistance, Type 2 Diabetes Mellitus, and Cardiovascular Disease: The End of the Beginning Circulation, November 15, 2005; 112(20): 3030 - 3032. [Full Text] [PDF]
|
|